Companies

Divi's Laboratories Q4 net up 33 per cent at ₹388 cr

Our Bureau Hyderabad | Updated on June 08, 2020

Divi's Laboratories Ltd's consolidated net profit increased 32.87 per cent at ₹388 crore in the fourth quarter ended March 31, 2020 as against ₹292 crore earned in the corresponding quarter of the previous financial year.

Consolidated total income of the company stood at ₹1,466.44 crore for the quarter under consideration. It was ₹1,307.97 crore for the same period year ago.

For the full year ended March 31, 2020, net profit and total revenue stood at ₹1,376 crore (₹1,352 cr) and ₹5,585 cr (₹5,102 cr) respectively.

The board of directors of the company had declared and paid an interim dividend of ₹16 per share for the financial year 2019-20. No final dividend is recommended, the drug-maker informed BSE.

Published on June 08, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor